2020

Last modified Mar. 29, 2020 12:54 PM by Tor Gjøen
Last modified Mar. 29, 2020 1:03 PM by Tor Gjøen
Last modified May 21, 2021 10:46 AM by lenkeretter@localhost

Information relating to COVID-19 pandemic from COST can be found here

Last modified Dec. 2, 2020 11:23 AM by Tor Gjøen

Leading Interational Vaccinology Education

A Programme of Excellence in Learning and Research, Looking for Biochemists, Bioengineers, Biologists, Clinicians, Pharmacists and Veterinarians

Last modified May 21, 2021 10:46 AM by lenkeretter@localhost

ENOVA partners publish review article on the use of adjuvants to boost therapeutic vaccines

 

Last modified Sep. 4, 2020 9:16 AM by Tor Gjøen
Last modified Feb. 28, 2020 11:11 PM by Tor Gjøen

Reports of ENOVA short term missions are now available on our website

Last modified Nov. 6, 2020 11:58 AM by Tor Gjøen

Open Call: Apply for TRANSVAC2 Vaccine Development Services

Last modified June 2, 2020 1:36 PM by Tor Gjøen

WHO today published a "draft landscape of COVID-19 candidate vaccines". A total of 133 vaccines (10 are in clinical trials) covering various platforms (inactivated virus, recombinant virus and proteins, VLPs, DNA/RNA vaccines) are listed. Adjuvants like Alum, Matrix M, AdvaxTM , CPG1018 and others are included as immune stimulants in the race for this vaccine.